Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR and crRNAs02:53

CRISPR and crRNAs

16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
Antibiotic Selection00:57

Antibiotic Selection

52.7K
Overview
52.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Bacterial Signaling01:30

Bacterial Signaling

31.9K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
31.9K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

20.9K
The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
20.9K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.

Cancer discovery·2026
Same author

Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Fluctuating DNA methylation tracks cancer evolution at clinical scale.

Nature·2025
Same author

Vancomycin-resistant enterococci utilise antibiotic-enriched nutrients for intestinal colonisation.

Nature communications·2025
Same author

Quantitative measurement of phenotype dynamics during cancer drug resistance evolution using genetic barcoding.

Nature communications·2025
Same author

Cell-cycle dependent DNA repair and replication unifies patterns of chromosome instability.

Nature communications·2025

Related Experiment Video

Updated: Jun 18, 2025

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli
08:25

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli

Published on: March 20, 2016

12.6K

A bacteriocin expression platform for targeting pathogenic bacterial species.

Jack W Rutter1, Linda Dekker1, Chania Clare1

  • 1Department of Cell and Developmental Biology, University College London, London, UK.

Nature Communications
|July 27, 2024
PubMed
Summary

Engineered bacteria can secrete bacteriocins, which are antimicrobial peptides, to combat antibiotic-resistant pathogens. This study developed a platform for targeted bacteriocin delivery, showing effectiveness against Enterococcus strains.

More Related Videos

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

13.6K
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
07:54

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

14.3K

Related Experiment Videos

Last Updated: Jun 18, 2025

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli
08:25

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli

Published on: March 20, 2016

12.6K
Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

13.6K
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
07:54

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

14.3K

Area of Science:

  • Microbiology
  • Biotechnology
  • Synthetic Biology

Background:

  • Bacteriocins are antimicrobial peptides with potential against antibiotic-resistant bacteria.
  • Engineered live biotherapeutic products (eLBPs) offer targeted bacteriocin delivery.
  • ESKAPE pathogens represent a significant threat due to antibiotic resistance.

Purpose of the Study:

  • To develop a modular platform for secreting multiple bacteriocins from non-pathogenic Escherichia coli.
  • To demonstrate the efficacy of engineered bacteriocin-secreting strains against pathogenic bacteria.
  • To model bacterial interactions using a Lotka-Volterra approach.

Main Methods:

  • Constructed a modular bacteriocin secretion platform in Escherichia coli.
  • Engineered strains secreting Enterocin A (EntA) and Enterocin B (EntB).
  • Evaluated antimicrobial activity in vitro using solid and liquid co-culture methods.
  • Developed a Lotka-Volterra model to simulate bacterial population dynamics.

Main Results:

  • Escherichia coli strains successfully secreted functional Enterocin A and Enterocin B.
  • Demonstrated significant in vitro antimicrobial activity against Enterococcus faecalis and Enterococcus faecium.
  • Simultaneous exposure to EntA and EntB delayed Enterococcus growth.
  • The Lotka-Volterra model captured competitor strain interactions.

Conclusions:

  • The developed platform enables targeted bacteriocin production for antimicrobial applications.
  • Engineered bacteriocin secretion shows promise as a strategy against antibiotic-resistant pathogens.
  • This approach could be developed into eLBPs for therapeutic use.